SOFIMED

The computed 12-month bankruptcy probability of SOFIMED is 2.2% (moderate). The 2025 annual accounts show equity of €160,598 and a net result of €165,823. Equity is growing by ~7.9% per year across the filed fiscal years. Its solvency ranks better than 18% of 910 sector peers (fiscal year 2025). The company has been active since 2019 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).